← Back to Clinical Trials
Recruiting NCT07426965

Stroke Hemiplegic Shoulder Pain: Ultrasound Findings and VAS (Cross-Sectional)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Hemiplegic Shoulder Pain
Sponsor Ankara Etlik City Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2026-02-17
Completion 2026-08

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Hemiplegic shoulder pain is a frequent complication after stroke and may be associated with structural abnormalities detectable by musculoskeletal ultrasound. This prospective cross-sectional observational study aims to evaluate the relationship between shoulder ultrasound abnormality score and pain severity in patients with post-stroke hemiplegic shoulder pain. Pain severity will be assessed using the Visual Analog Scale (VAS) for rest, movement, and night pain. Shoulder ultrasound will be performed using a standardized scoring system to quantify structural abnormalities. The primary objective is to investigate whether ultrasound abnormality burden is associated with pain severity in different clinical conditions (rest, exercise, and night).

Eligibility Criteria

Inclusion Criteria: 1. Being between 18-75 years of age 2. Patients with a history of stroke within the last 2 weeks to 6 months 3. Patients with shoulder pain on the hemiplegic side 4. Mini-mental status test score \>25 Exclusion Criteria: 1. Motor aphasic patient group 2. Patients with a history of previous surgery on the hemiplegic shoulder for any reason 3. Those with other diseases that can explain the shoulder pain 4. Those with neurodegenerative diseases that cause impairment in cognitive functions, such as dementia

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}